From: Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
Age ≥ 71.2 years
Hb < 11.0 g/dL
LDH ≥ 262 IU/L
aBSI≥1.0%
Low risk (n = 26), n (%)
8 (30.8)
5 (19.2)
6 (23.1)
13 (50.0)
High risk (n = 22), n (%)
16(72.7)
18 (81.8)